Trial Profile
New assessment of therapeutic response to sorafenib for advanced hepatocellular carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Jun 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 20 Jun 2015 New trial record